|5.16||-0.0500||-0.96%||Vol 486.57K||1Y Perf 190.96%|
|Apr 19th, 2021 16:00 DELAYED|
|- -||- -%|
|Target Price||7.33||Analyst Rating||Moderate Buy 2.00|
|Potential %||42.05||Finscreener Ranking||★★+ 48.17|
|Insiders Trans % 3/6/12 mo.||-100/-75/-80||Value Ranking||★+ 43.30|
|Insiders Value % 3/6/12 mo.||-100/-23/-32||Growth Ranking||★★+ 48.72|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-21/-34||Income Ranking||— -|
|Market Cap||479.35M||Earnings Rating||Neutral|
|Price Range Ratio 52W %||80.37||Earnings Date||27th Apr 2021|
Today's Price Range
5 Year PE Ratio Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||27th Apr 2021|
|Estimated EPS Next Report||0.01|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||404.32K|
|Avg. Monthly Volume||597.42K|
|Avg. Quarterly Volume||868.61K|
Accuray Incorporated (NASDAQ: ARAY) stock closed at 5.16 per share at the end of the most recent trading day (a -0.96% change compared to the prior day closing price) with a volume of 486.58K shares and market capitalization of 479.35M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 932 people. Accuray Incorporated CEO is Joshua H. Levine.
The one-year performance of Accuray Incorporated stock is 190.96%, while year-to-date (YTD) performance is 23.74%. ARAY stock has a five-year performance of -15.41%. Its 52-week range is between 1.68 and 6.01, which gives ARAY stock a 52-week price range ratio of 80.37%
Accuray Incorporated currently has a PE ratio of 61.70, a price-to-book (PB) ratio of 6.22, a price-to-sale (PS) ratio of 1.73, a price to cashflow ratio of 20.70, a PEG ratio of 2.32, a ROA of 1.53%, a ROC of 2.72% and a ROE of 11.02%. The company’s profit margin is 1.76%, its EBITDA margin is 12.00%, and its revenue ttm is $277.77 Million , which makes it $2.99 revenue per share.
Of the last four earnings reports from Accuray Incorporated, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.01 for the next earnings report. Accuray Incorporated’s next earnings report date is 27th Apr 2021.
The consensus rating of Wall Street analysts for Accuray Incorporated is Moderate Buy (2), with a target price of $7.33, which is +42.05% compared to the current price. The earnings rating for Accuray Incorporated stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Accuray Incorporated has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Accuray Incorporated has a Neutral technical analysis rating based on Technical Indicators (ADX : 11.76, ATR14 : 0.27, CCI20 : 46.61, Chaikin Money Flow : -0.08, MACD : -0.01, Money Flow Index : 74.13, ROC : 4.24, RSI : 46.97, STOCH (14,3) : 73.49, STOCH RSI : 0.00, UO : 52.23, Williams %R : -26.51), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Accuray Incorporated in the last 12-months were: Jesse Chew (Sold 9 009 shares of value $28 020 ), Joseph E. Whitters (Buy at a value of $173 135), Joshua H. Levine (Sold 31 044 shares of value $101 170 ), Michael Hoge (Sold 11 268 shares of value $62 199 ), Patrick Spine (Sold 6 425 shares of value $19 407 ), Shigeyuki Hamamatsu (Sold 19 294 shares of value $53 187 ), Suzanne Winter (Sold 23 740 shares of value $71 714 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.